The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b extension study of cancer stemness inhibitor BB608 (napabucasin) administered in combination with FOLFIRI +/- bevacizumab (Bev) in patients (pts) with advanced colorectal cancer (CRC).
 
Bert H. O'Neil
Consulting or Advisory Role - Acceleron Pharma; Amgen; Bayer; Genentech/Roche; Lilly/ImClone; Sanofi
Speakers' Bureau - Amgen
 
Joleen Marie Hubbard
Consulting or Advisory Role - Bayer (Inst)
Research Funding - Boston Biomedical (Inst); Genentech (Inst); PRISM Pharma (Inst); Senhwa Biosciences (Inst)
 
Alexander Starodub
Consulting or Advisory Role - Bayer; Sandoz
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Sandoz
 
Derek J. Jonker
No Relationships to Disclose
 
William Jeffery Edenfield
No Relationships to Disclose
 
Bassel F. El-Rayes
Consulting or Advisory Role - Genentech/Roche; Merrimack; Merrimack
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Genentech (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Thorvardur Ragnar Halfdanarson
Consulting or Advisory Role - Novartis
 
Ramesh K. Ramanathan
Honoraria - Celgene; Cerulean Pharma; Lilly; Pharmacyclics; Taiho Pharmaceutical; Vaccinex
Consulting or Advisory Role - Celgene; Genentech; Lilly; Vaccinex
Research Funding - Abbvie; Bayer; Biomarin; Celgene; Genentech; Halozyme; Merck/Schering Plough; Merrimack; Sanofi; Tekmira; Vaccinex; Verastem
Travel, Accommodations, Expenses - Biomarin
Other Relationship - Celgene
 
Henry C. Pitot
No Relationships to Disclose
 
Carolyn D. Britten
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); EMD Serono (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst); Roche (Inst)
 
Bamidele Adesunloye
No Relationships to Disclose
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Laura Borodyansky
Employment - Boston Biomedical
 
Chiang Li
Employment - Boston Biomedical
Leadership - Boston Biomedical
Stock and Other Ownership Interests - Boston Biomedical
Speakers' Bureau - Boston Biomedical
Patents, Royalties, Other Intellectual Property - Boston Biomedical